Literature DB >> 16124065

Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model.

Jian-Gao Fan1, Zheng-Jie Xu, Guo-Liang Wang.   

Abstract

AIM: To explore the relationship between changes of intestinal environment and pathogenesis of non-alcoholic steatohepatitis (NASH).
METHODS: Forty-two Sprague-Dawley rats were randomly divided into model group (n = 24), treatment group (n = 12), and control group (n = 6). The rats of model and treatment groups were given high-fat diet, and those of the control group were given normal diet. Furthermore, the rats of treatment group were given lactulose after 8 wk of high-fat diet. Twelve rats of the model group were killed at 8 wk of high-fat diet. At the 16 wk the rats of treatment group, control group, and the rest of the model group were killed. The serum levels of aminotransferase were measured and the histology of livers was observed by H and E staining.
RESULTS: The livers of rats presented the pathological features of steatohepatitis with higher serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the model group after 16 wk. Compared to the model group, the serum levels of ALT and AST in treatment group decreased significantly and were close to the normal group, and the hepatic inflammation scores also decreased markedly than those in the model group after 16 wk (5.83+/-2.02 vs 3.63+/-0.64, P<0.05), but were still higher than those in the model group after 8 wk (3.63+/-0.64 vs 1.98+/-0.90, P<0.05). However, the degree of hepatic steatosis had no changes in treatment group compared to the model group after 16 wk.
CONCLUSION: Lactulose could ameliorate the hepatic inflammation of rats with steatohepatitis induced by fat-rich diet, but could not completely prevent the development of steatohepatitis. It is suggested that intestinal environmental changes such as intestinal bacteria overgrowth, are one of the important factors in the pathogenesis of NASH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16124065      PMCID: PMC4321929          DOI: 10.3748/wjg.v11.i32.5053

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

2.  Total parenteral nutrition promotes bacterial translocation from the gut.

Authors:  J C Alverdy; E Aoys; G S Moss
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

Review 3.  Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection.

Authors:  S Salminen; E Salminen
Journal:  Scand J Gastroenterol Suppl       Date:  1997

Review 4.  Jejunoileal bypass: change in the flora of the small intestine and its clinical impact.

Authors:  P Corrodi
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

Review 5.  Etiopathogenesis of nonalcoholic steatohepatitis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

6.  The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.

Authors:  Stephen A Harrison; Sigurd Torgerson; Paul H Hayashi
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

Review 7.  The role of gut-derived bacterial toxins and free radicals in alcohol-induced liver injury.

Authors:  R G Thurman; B U Bradford; Y Iimuro; K T Knecht; G E Arteel; M Yin; H D Connor; C Wall; J A Raleigh; M V Frankenberg; Y Adachi; D T Forman; D Brenner; M Kadiiska; R P Mason
Journal:  J Gastroenterol Hepatol       Date:  1998-09       Impact factor: 4.029

8.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

9.  Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide.

Authors:  I Pappo; H Bercovier; E M Berry; Y Haviv; R Gallily; H R Freund
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Nov-Dec       Impact factor: 4.016

Review 10.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin.

Authors:  R G Thurman
Journal:  Am J Physiol       Date:  1998-10
View more
  14 in total

1.  Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Authors:  Gil Weitzman; Neil J Schamberg; Gerond Lake-Bakaar
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

2.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

3.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 4.  Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy.

Authors:  Junli Ma; Qihang Zhou; Houkai Li
Journal:  Nutrients       Date:  2017-10-16       Impact factor: 5.717

Review 5.  Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.

Authors:  Hamed Ebrahimzadeh Leylabadlo; Reza Ghotaslou; Hossein Samadi Kafil; Mohammad Mehdi Feizabadi; Seyed Yaghoub Moaddab; Safar Farajnia; Elham Sheykhsaran; Sarvin Sanaie; Dariush Shanehbandi; Hossein Bannazadeh Baghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-11       Impact factor: 3.267

6.  Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats.

Authors:  Wan-Chun Wu; Wei Zhao; Sheng Li
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

Review 7.  Childhood obesity: immune response and nutritional approaches.

Authors:  Thea Magrone; Emilio Jirillo
Journal:  Front Immunol       Date:  2015-02-24       Impact factor: 7.561

Review 8.  Non-alcoholic fatty liver disease in children: focus on nutritional interventions.

Authors:  Min Yang; Sitang Gong; Shui Qing Ye; Beth Lyman; Lanlan Geng; Peiyu Chen; Ding-You Li
Journal:  Nutrients       Date:  2014-10-28       Impact factor: 5.717

9.  Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats.

Authors:  Zheng-Jie Xu; Jian-Gao Fan; Xiao-Dong Ding; Liang Qiao; Guo-Liang Wang
Journal:  Dig Dis Sci       Date:  2009-05-21       Impact factor: 3.199

Review 10.  Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Authors:  Kento Imajo; Masato Yoneda; Takaomi Kessoku; Yuji Ogawa; Shin Maeda; Yoshio Sumida; Hideyuki Hyogo; Yuichiro Eguchi; Koichiro Wada; Atsushi Nakajima
Journal:  Int J Mol Sci       Date:  2013-11-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.